Insider Transactions Reported by 7 Insiders of Hoth Therapeutics, Inc.

Symbol
HOTH on Nasdaq
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 02 Feb 2025

Hoth Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robb Knie CEO and President, Director $662,338 27 Aug 2025
Graig Springer Director 14 Jan 2025
Stefanie Johns Chief Scientific Officer 16 Mar 2022
David Sarnoff Director 19 Aug 2024
Wayne Linsley Director 19 Aug 2024
Jeff Pavell Director 19 Aug 2024
Christopher Michael Camarra Director 08 May 2025

Recent Insider Transactions by Companies or Individuals for Hoth Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.